Roche-Spark tender offer extended to December 16 for US, UK regulatory review
MLex Summary: Roche has again extended the tender offer for shares of Spark Therapeutics, this time from Dec. 10 to Dec. 16. The extension is to provide more time for the...To view the full article, register now.
Already a subscriber? Click here to view full article